Focus: Hologic is a $4.0B medical device company headquartered in Massachusetts, specializing in diagnostics and surgical systems across women's health, oncology, and infectious disease. The company operates at significant scale with 5,001-10,000 employees and maintains a strong balance sheet as a public entity.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Hologic to get notified when they start hiring — the background below is worth knowing for when they do.
Recently secured FDA approval for primary HPV screening, representing a major commercial inflection point for cervical cancer prevention.
Help build intelligence for Hologic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Hologic's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core franchise technology with multiple clinical studies validating efficacy; reduces recall rates and improves cancer detection.
Established women's health procedure with strong installed base; represents recurring revenue opportunity through physician adoption.
Bacterial Vaginosis Market Is Going to Boom | Abbott Laboratories • Quidel Corporation • Hologic - openPR.com
Bacterial Vaginosis Market Is Going to Boom | Abbott Laboratories • Quidel Corporation • Hologic openPR.com
Hologic finds women’s health stagnating over 5 years of surveys - Fierce Pharma
Hologic finds women’s health stagnating over 5 years of surveys Fierce Pharma
Hologic’s VP of marketing on the company’s WNBA foray - Campaign US
Hologic’s VP of marketing on the company’s WNBA foray Campaign US
8-K Filing: EXACT SCIENCES CORP (EXAS) (CIK 0001124140) — 8-K
8-K
Hologic’s Aptima assay secures FDA approval for HPV primary screening - Medical Device Network
Hologic’s Aptima assay secures FDA approval for HPV primary screening Medical Device Network
FDA Expands HPV Primary Screening Options - Conexiant
FDA Expands HPV Primary Screening Options Conexiant
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Identifying premenopausal patients with early-stage hormone receptor-positive breast cancer at minimal risk of distant recurrence by breast cancer index.
TORC1-dependent translation drives chromatin remodeling during the germ-cell-to-maternal transition in Drosophila.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo